We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The European Medicines Agency yesterday announced a new system for reporting drug shortages and potential supply disruptions as the COVID-19 pandemic takes a toll on the stock of some critical medicines. Read More
Gilead CEO Daniel O’Day announced that the company is ramping up production of its antiviral remdesivir for COVID-19 and hopes to have 500,000 treatment courses by October, and more than 1 million treatment courses by the end of the year. Read More
Inovio announced yesterday that the FDA signed off on the company’s investigational NDA for its COVID-19 vaccine candidate INO-4800, clearing the way for a clinical trial. Read More
President Trump has reached out to India’s Prime Minister Narendra Modi following India’s export freeze on the COVID-19 treatment hydroxychloroquine, calling for an exception to the country’s new restrictions. Read More
The FDA hit a Farmingdale, New York generic drugmaker with a Form 483 for a large number of violations, including inadequate complaint investigations and multiple issues with testing. Read More